Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances
Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighte...
Saved in:
Published in | Transplant infectious disease Vol. 25; no. S1; pp. e14117 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Wiley Subscription Services, Inc
01.11.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1398-2273 1399-3062 1399-3062 |
DOI | 10.1111/tid.14117 |
Cover
Abstract | Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo‐HCT recipients, face when infected with SARS‐CoV‐2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo‐HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo‐HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics. |
---|---|
AbstractList | Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics. Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of allogeneic hematopoietic cell transplant (allo-HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo-HCT recipients, face when infected with SARS-CoV-2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo-HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo-HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics. |
Author | Navarro, David García‐Cadenas, Irene Piñana, Jose L. Martino, Rodrigo Solano, Carlos Chorão, Pedro Pérez, Ariadna Guerreiro, Manuel |
Author_xml | – sequence: 1 givenname: Jose L. orcidid: 0000-0001-8533-2562 surname: Piñana fullname: Piñana, Jose L. email: jlpinana@gmail.com organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia – sequence: 2 givenname: Ariadna surname: Pérez fullname: Pérez, Ariadna organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia – sequence: 3 givenname: Pedro orcidid: 0000-0001-6741-971X surname: Chorão fullname: Chorão, Pedro organization: Hospital Universitário y Politécncio La Fe – sequence: 4 givenname: Manuel surname: Guerreiro fullname: Guerreiro, Manuel organization: Hospital Universitário y Politécncio La Fe – sequence: 5 givenname: Irene surname: García‐Cadenas fullname: García‐Cadenas, Irene organization: Hospital de la Santa Creu i Sant Pau – sequence: 6 givenname: Carlos surname: Solano fullname: Solano, Carlos organization: Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia – sequence: 7 givenname: Rodrigo surname: Martino fullname: Martino, Rodrigo organization: Hospital de la Santa Creu i Sant Pau – sequence: 8 givenname: David orcidid: 0000-0003-3010-4110 surname: Navarro fullname: Navarro, David organization: School of Medicine, University of Valencia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37585370$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kV1rHCEYhaWkNMm2F_0DRehNC5nEj51Re1c2_QgECiW9FkffWUxndapOwl73j8fNbm5C64WKPOfwes4pOgoxAEJvKTmndV0U787pklLxAp1QrlTDSceOHu-yYUzwY3Sa8y0hVKileoWOuWhlywU5QX9_Qp58MiWmLb7zac7YhwFs8TFkbIYCCZtxjGsI4C3OBTbYwjjikkzI02hCMTv2E17NKUEoeA4OUi4mOB_WZ_h3iPcjuDXgtZnyGa7vOIHdkcbdmWAhv0YvBzNmeHM4F-jX1y83q-_N9Y9vV6vP143lddhGcco6wdu-5SCWlopOGeP6XhDZ9oR3qlNiYHJY9iCdJNJZQZyTTDFqjZCOL9CHve-U4p8ZctEbn3efMQHinDWTLes4k3VboPfP0Ns4p1Cnq5RSlakRVurdgZr7DTg9Jb8xaauf4q3AxR6wKeacYNDW7_Oq8flRU6J3BepaoH4ssCo-PlM8mf6LPbjf-xG2_wf1zdXlXvEAejCrTQ |
CitedBy_id | crossref_primary_10_1038_s41409_025_02536_y crossref_primary_10_3389_fonc_2024_1389345 crossref_primary_10_1097_MD_0000000000041683 crossref_primary_10_1093_cid_ciae602 crossref_primary_10_2147_IDR_S427762 crossref_primary_10_1007_s15010_024_02213_0 crossref_primary_10_1038_s41409_024_02304_4 crossref_primary_10_1016_j_jtct_2025_02_012 crossref_primary_10_1016_j_retram_2024_103461 |
Cites_doi | 10.1016/S0140-6736(22)02597-1 10.1128/JCM.00789-11 10.1097/01.md.0000232560.22098.4e 10.1093/jac/dkt111 10.1016/j.bbmt.2009.06.019 10.1016/j.cmi.2020.11.004 10.1016/j.ccm.2016.11.010 10.1371/journal.pone.0271756 10.1016/j.bbmt.2012.12.019 10.1086/598627 10.1093/cid/ciy584 10.1016/j.bbmt.2018.08.021 10.1093/infdis/jiz656 10.1093/cid/cit639 10.1016/j.canlet.2016.05.035 10.1097/COH.0000000000000794 10.1128/AAC.00766-18 10.1002/ajh.26385 10.1182/blood-2002-02-0377 10.1128/jcm.01785-21 10.1164/rccm.200212‐1468OC 10.1016/S2213‐2600(22)00412‐X 10.1056/NEJMoa2001282 10.1111/tid.13276 10.3324/haematol.2018.215152 10.3390/ijms24054847 10.1016/j.canlet.2015.11.014 10.1111/tid.13301 10.1016/S0140-6736(22)00519-0 10.1016/j.bbmt.2013.05.005 10.1093/cid/ciu623 10.1056/NEJMoa2208822 10.1128/JCM.00367-18 10.7883/yoken.JJID.2017.424 10.1016/j.bbmt.2016.07.005 10.1182/blood‐2010‐11‐319186 10.1038/s41598-021-02972-y 10.1016/S2213-2600(16)30435-0 10.18632/oncotarget.10182 10.1016/j.bbmt.2015.11.015 10.1016/j.cmi.2021.11.007 10.1186/s13045-022-01250-2 10.1086/344899 10.1164/rccm.200604-489OC 10.1093/cid/ciy760 10.1128/CMR.00116-13 10.1002/cpt.2646 10.1111/tid.13415 10.1016/S1473-3099(14)70717-0 10.1016/j.cmi.2015.12.012 10.3324/haematol.2014.116772 10.1111/bjh.16216 10.1016/j.bbmt.2005.07.007 10.1016/S0140-6736(20)32013-4 10.1038/bmt.2008.264 10.1016/j.bbmt.2019.12.724 10.1038/s41375-021-01302-5 10.1093/cid/ciaa1764 10.1038/s41375‐021‐01302‐5 10.1002/jmv.21548 10.1093/infdis/jiaa553 10.1182/blood‐2021‐147274 10.1016/j.bbmt.2010.07.018 10.1056/NEJMsb2104756 10.1016/j.bbmt.2012.04.012 10.1038/bmt.2017.24 10.1093/cid/ciw284 10.1056/NEJMoa2031994 10.3389/fmicb.2018.02478 10.1182/bloodadvances.2020003865 10.1371/journal.pone.0148258 10.1038/s41408-022-00778-3 10.1038/sj.bmt.1703139 10.1002/iid3.502 10.1093/jac/dkab243 10.1080/10428194.2018.1468896 10.3390/v14020267 10.1093/cid/ciaa1149 10.1093/infdis/jiy547 10.1016/j.cmi.2019.10.012 10.1086/422994 10.1128/JCM.02151‐12 10.3324/haematol.2022.281946 10.1038/bmt.2013.94 10.3390/microorganisms10091856 10.1016/j.bbmt.2009.09.014 10.1183/13993003.03725-2020 10.1093/cid/ciab371 10.1007/s00705‐013‐1610‐1 10.1128/JCM.02264-16 10.1186/s40164‐020‐00177‐z 10.1038/sj.bmt.1703083 10.1016/j.jtct.2022.09.002 10.1093/cid/ciac312 10.1093/infdis/jiab391 10.1111/irv.12972 10.1016/j.coviro.2016.01.016 10.1056/NEJMoa2116044 10.1111/tid.13158 10.1182/blood.V98.3.573 10.3389/fphar.2021.683296 10.1038/s41564-022-01143-7 10.1111/bjh.17651 10.1086/432732 10.1016/S1473-3099(21)00485-0 10.1038/s41409-019-0728-5 10.1097/INF.0b013e3181f12fcf 10.1086/525263 10.1093/infdis/jix358 10.1038/s41409‐019‐0698‐7 10.1016/j.bbmt.2017.11.001 10.1016/j.idc.2019.02.004 10.7326/0003-4819-144-5-200603070-00010 10.1093/infdis/jiad268 10.1016/j.bbmt.2012.10.014 10.1128/JCM.06579-11 10.1038/bmt.2009.78 10.1038/s41408‐022‐00778‐3 10.1056/NEJMoa2106062 10.1056/NEJMoa2033130 10.1016/j.healun.2007.05.020 10.1016/j.jinf.2019.12.022 10.1016/S1473-3099(09)70175-6 10.3201/eid1309.070318 10.1182/blood-2009-11-255455 10.1111/tid.12111 10.3324/haematol.2016.153767 10.1093/cid/cis844 10.1111/tid.12926 10.1038/s41598-021-97700-x 10.1111/j.1365-2141.2006.06108.x 10.1086/375069 10.1182/blood.2022016202 10.1016/j.cmi.2022.04.018 10.1111/tid.12729 10.1016/j.bbmt.2009.12.534 10.1038/s41409‐023‐01946‐0 10.1016/j.bbmt.2018.07.006 10.1007/s40121-019-00271-8 10.1128/JCM.01816-15 10.1038/sj.bmt.1705781 10.1182/blood-2009-09-244152 10.1016/S2213-2600(21)00331-3 10.1016/j.bbmt.2018.12.005 10.3389/fimmu.2023.1125824 10.1128/CMR.00010‐16 10.1128/JVI.01659-16 10.1186/s12916-022-02518-7 10.1016/j.bbmt.2018.05.016 10.1111/tid.12167 10.1128/JCM.39.2.801-803.2001 10.1038/s41409‐020‐0943‐0 10.1038/s41409‐021‐01319‐5 10.1016/S0140‐6736(21)01594‐4 10.1093/infdis/jix264 10.3324/haematol.2018.206896 10.1038/s41409‐021‐01462‐z 10.1016/j.jcv.2015.04.012 10.1093/cid/civ272 10.1093/cid/ciu134 10.1086/504268 10.1056/NEJMc2031364 10.14745/ccdr.v47i03a02 10.1111/j.1399‐3062.2008.00362.x 10.1186/s13045‐022‐01275‐7 10.1016/j.bbmt.2018.03.004 10.1182/blood‐2011‐08‐371112 10.1002/rmv.2375 10.1016/j.cmi.2021.05.020 10.1093/cid/ciy874 10.3109/10428194.2015.1113279 10.1093/cid/ciy792 10.1007/s40291-022-00580-8 10.1128/JVI.01631‐14 10.3390/v13081665 10.1016/j.bbmt.2012.11.139 10.1093/infdis/jit832 10.1093/infdis/jis610 10.1182/blood-2006-12-060343 10.1002/jmv.28471 10.1111/tid.12054 10.1016/j.jcv.2022.105152 10.1093/infdis/jix203 10.1093/cid/cix160 10.1111/tid.12022 10.1016/j.diagmicrobio.2015.10.025 10.1111/j.1365-2141.2009.07654.x 10.1086/425004 10.1111/ejh.12094 10.1016/j.bbmt.2018.11.022 10.1016/j.ccell.2022.02.012 10.3109/10428194.2015.1067699 10.1056/NEJMc2031670 10.1128/aac.00452-22 10.1182/blood-2003-05-1425 10.1182/blood‐2022‐167773 10.1016/j.cmi.2017.11.018 10.1038/s41409‐022‐01575‐z 10.1128/cmr.00168-21 10.1182/bloodadvances.2021004915 10.3389/fimmu.2018.00678 10.1093/infdis/jiab611 10.1007/s00134-021-06448-5 10.1182/blood-2010-11-319186 10.1016/S1473-3099(20)30004-9 10.1097/QCO.0b013e3283480440 10.1111/tid.13792 10.1093/jac/dkab245 10.1007/s15010-012-0279-9 10.1182/blood-2013-12-541359 10.3324/haematol.2021.280407 10.1111/tid.13602 10.1016/j.ijid.2023.03.045 10.1093/infdis/jiac135 10.1093/ofid/ofy077 10.1038/s41409‐022‐01790‐8 10.1038/s41409‐018‐0386‐z 10.1038/sj.bmt.1704359 10.1016/S1473‐3099(18)30600‐5 10.1128/spectrum.00503-22 10.1016/j.bbmt.2010.09.014 |
ContentType | Journal Article |
Copyright | 2023 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2023 Wiley Periodicals LLC. |
CorporateAuthor | the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC) Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) |
CorporateAuthor_xml | – name: the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC) – name: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7U9 8FD FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1111/tid.14117 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1399-3062 |
EndPage | n/a |
ExternalDocumentID | 37585370 10_1111_tid_14117 TID14117 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OC 29Q 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADXAS ADZCM AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY CITATION CGR CUY CVF ECM EIF NPM 7QO 7U9 8FD FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3537-93126735b53e74c1769aadbb7085b0369697f28f4be8d808dc70dd82921ca78d3 |
IEDL.DBID | DR2 |
ISSN | 1398-2273 1399-3062 |
IngestDate | Wed Oct 01 13:43:46 EDT 2025 Fri Jul 25 23:17:58 EDT 2025 Mon Jul 21 06:01:06 EDT 2025 Wed Oct 01 02:09:33 EDT 2025 Thu Apr 24 23:03:49 EDT 2025 Wed Jan 22 16:15:18 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S1 |
Keywords | respiratory virus rhinovirus COVID-19 community acquired respiratory virus (CARV) SARS-CoV-2 allogeneic stem cell transplantation vaccines.VRS adenovirus influenza virus human adenovirus human parainfluenza virus human metapneumovirus human seasonal coronavirus human bocavirus |
Language | English |
License | 2023 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3537-93126735b53e74c1769aadbb7085b0369697f28f4be8d808dc70dd82921ca78d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0001-8533-2562 0000-0001-6741-971X 0000-0003-3010-4110 |
PMID | 37585370 |
PQID | 2899282375 |
PQPubID | 1096379 |
PageCount | 22 |
ParticipantIDs | proquest_miscellaneous_2852632826 proquest_journals_2899282375 pubmed_primary_37585370 crossref_citationtrail_10_1111_tid_14117 crossref_primary_10_1111_tid_14117 wiley_primary_10_1111_tid_14117_TID14117 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2023 2023-11-00 2023-Nov 20231101 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: November 2023 |
PublicationDecade | 2020 |
PublicationPlace | Denmark |
PublicationPlace_xml | – name: Denmark – name: Malden |
PublicationTitle | Transplant infectious disease |
PublicationTitleAlternate | Transpl Infect Dis |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2010; 16 2011; 117 2009; 81 2020; 20 2013; 68 2006; 174 2014; 27 2022; 24 2019; 19 2022; 26 2012; 18 2022; 20 2022; 22 2012; 14 2009;; 11 2021; 73 2022; 28 2004; 33 2018; 9 2021; 76 2018; 5 2023; 67 2021; 398 2013; 57 2013; 56 2004; 39 2022; 40 2019; 21 2013; 51 2010; 115 2019; 25 2014; 16 2022; 35 2014; 14 2022; 32 2003; 168 2009; 15 2014; 123 2021; 47 2019; 8 2022; 112 2005; 192 2017; 64 2020; 383 2020; 382 2019; 33 1999; 29 2015; 53 2019; 104 2003; 36 2013; 90 2021; 384 2001; 28 2021; 385 2006; 193 2016; 16 2018; 20 2007; 13 2018; 24 2016; 11 2012; 50 2021; 58 2015; 68 2016; 7 2017; 52 2021; 56 2022; 150‐151 2020; 396 2022; 6 2015; 61 2017; 55 2022; 7 2021; 138 2022; 14 2020; 26 2008; 46 2022; 15 2019; 219 2022; 97 2020; 22 2022; 10 2001; 39 2008; 42 2022; 108 2022; S2213‐2600 2022; 107 2005; 11 2022; 16 2022; 225 2012; 119 2022; 17 2022; 226 2016; 22 2012; 40 2017; 5 2009; 44 2021; 27 2021; 23 2023; 141 2019; 54 2023; 388 2015; 100 2023; S1201‐9712 2023; 1 2020; 55 2011; 17 2012; 206 2006; 134 2013; 19 2021; 35 2017; 30 2023; 24 2013; 15 2019; 60 2014; 209 2017; 38 2019; 68 2002; 100 2020; 9 2014; 59 2021; 195 2014; 58 2013; 158 2016; 84 2011; 24 2022; 75 2018; 71 2007; 26 2005; 35 2001; 98 2021; 9 2023; 95 2023; 13 2013; 48 2021; 5 2023; 14 2004; 103 2021; 223 2023; 18 2020; 80 2011; 30 2020; 105 2023; 401 2020; 188 2020; 221 2018; 62 2018; 67 2016; 57 2014; 88 2017; 216 2022; 399 2022; 386 2021; 13 2022; 140 2006; 85 2012; 2 2017; 91 2021; 12 2021; 11 2023 2022; 60 2022 2023; 195 2020 2007; 110 2022; 57 2016; 63 2009; 9 2009; 145 2017; 19 2016; 379 2007; 40 2018; 56 2011; 49 2017; 102 2006; 144 2016; 370 e_1_2_16_23_1 e_1_2_16_46_1 e_1_2_16_222_1 e_1_2_16_69_1 Shah DP (e_1_2_16_150_1) 2012; 2 e_1_2_16_113_1 e_1_2_16_136_1 e_1_2_16_159_1 e_1_2_16_84_1 e_1_2_16_61_1 e_1_2_16_101_1 e_1_2_16_162_1 e_1_2_16_185_1 e_1_2_16_234_1 e_1_2_16_219_1 e_1_2_16_19_1 e_1_2_16_34_1 e_1_2_16_57_1 e_1_2_16_210_1 e_1_2_16_233_1 e_1_2_16_11_1 e_1_2_16_109_1 e_1_2_16_124_1 e_1_2_16_147_1 e_1_2_16_95_1 e_1_2_16_72_1 e_1_2_16_9_1 e_1_2_16_112_1 e_1_2_16_196_1 e_1_2_16_173_1 e_1_2_16_207_1 e_1_2_16_45_1 e_1_2_16_68_1 Pagano L (e_1_2_16_183_1) 2022 e_1_2_16_200_1 e_1_2_16_22_1 e_1_2_16_60_1 e_1_2_16_83_1 e_1_2_16_114_1 e_1_2_16_137_1 e_1_2_16_186_1 e_1_2_16_163_1 e_1_2_16_212_1 e_1_2_16_18_1 e_1_2_16_56_1 e_1_2_16_211_1 e_1_2_16_79_1 e_1_2_16_33_1 e_1_2_16_102_1 e_1_2_16_71_1 e_1_2_16_94_1 e_1_2_16_10_1 e_1_2_16_125_1 e_1_2_16_148_1 e_1_2_16_8_1 e_1_2_16_197_1 e_1_2_16_151_1 e_1_2_16_174_1 e_1_2_16_223_1 e_1_2_16_208_1 e_1_2_16_29_1 e_1_2_16_67_1 e_1_2_16_220_1 e_1_2_16_119_1 e_1_2_16_44_1 Schwartz K (e_1_2_16_131_1) 2023; 195 e_1_2_16_21_1 e_1_2_16_157_1 e_1_2_16_82_1 e_1_2_16_122_1 e_1_2_16_145_1 e_1_2_16_160_1 e_1_2_16_217_1 e_1_2_16_17_1 e_1_2_16_78_1 e_1_2_16_231_1 e_1_2_16_32_1 e_1_2_16_55_1 Tol MJ (e_1_2_16_192_1) 2005; 35 e_1_2_16_70_1 e_1_2_16_107_1 e_1_2_16_168_1 e_1_2_16_93_1 e_1_2_16_110_1 e_1_2_16_156_1 e_1_2_16_133_1 e_1_2_16_3_1 e_1_2_16_171_1 e_1_2_16_194_1 e_1_2_16_205_1 e_1_2_16_228_1 e_1_2_16_221_1 e_1_2_16_28_1 e_1_2_16_89_1 e_1_2_16_2_1 e_1_2_16_43_1 e_1_2_16_66_1 e_1_2_16_135_1 e_1_2_16_20_1 e_1_2_16_81_1 e_1_2_16_158_1 Grundeis F (e_1_2_16_140_1) 2023; 1 e_1_2_16_123_1 e_1_2_16_100_1 e_1_2_16_184_1 e_1_2_16_161_1 e_1_2_16_218_1 e_1_2_16_39_1 e_1_2_16_232_1 e_1_2_16_16_1 e_1_2_16_31_1 e_1_2_16_77_1 e_1_2_16_54_1 e_1_2_16_108_1 e_1_2_16_146_1 e_1_2_16_92_1 e_1_2_16_169_1 e_1_2_16_111_1 e_1_2_16_134_1 e_1_2_16_195_1 e_1_2_16_172_1 e_1_2_16_206_1 e_1_2_16_229_1 e_1_2_16_27_1 e_1_2_16_117_1 e_1_2_16_42_1 e_1_2_16_88_1 e_1_2_16_65_1 e_1_2_16_120_1 e_1_2_16_143_1 e_1_2_16_166_1 e_1_2_16_189_1 e_1_2_16_80_1 e_1_2_16_181_1 e_1_2_16_215_1 e_1_2_16_15_1 e_1_2_16_38_1 e_1_2_16_30_1 e_1_2_16_53_1 e_1_2_16_76_1 e_1_2_16_99_1 e_1_2_16_105_1 e_1_2_16_128_1 e_1_2_16_91_1 e_1_2_16_177_1 e_1_2_16_154_1 e_1_2_16_5_1 Centers for Disease Control and Prevention (e_1_2_16_37_1) 2020 e_1_2_16_226_1 e_1_2_16_203_1 e_1_2_16_26_1 e_1_2_16_49_1 e_1_2_16_41_1 e_1_2_16_64_1 e_1_2_16_87_1 e_1_2_16_118_1 e_1_2_16_179_1 e_1_2_16_121_1 e_1_2_16_167_1 e_1_2_16_144_1 e_1_2_16_182_1 e_1_2_16_216_1 e_1_2_16_14_1 e_1_2_16_230_1 e_1_2_16_98_1 e_1_2_16_52_1 e_1_2_16_129_1 e_1_2_16_75_1 e_1_2_16_106_1 e_1_2_16_90_1 e_1_2_16_132_1 e_1_2_16_155_1 e_1_2_16_178_1 e_1_2_16_4_1 e_1_2_16_193_1 e_1_2_16_170_1 e_1_2_16_204_1 e_1_2_16_227_1 e_1_2_16_25_1 e_1_2_16_48_1 e_1_2_16_63_1 e_1_2_16_86_1 e_1_2_16_115_1 e_1_2_16_138_1 e_1_2_16_40_1 e_1_2_16_164_1 e_1_2_16_187_1 e_1_2_16_141_1 e_1_2_16_213_1 e_1_2_16_13_1 e_1_2_16_36_1 e_1_2_16_59_1 e_1_2_16_74_1 e_1_2_16_103_1 e_1_2_16_97_1 e_1_2_16_51_1 e_1_2_16_126_1 e_1_2_16_149_1 e_1_2_16_7_1 e_1_2_16_209_1 e_1_2_16_198_1 e_1_2_16_175_1 e_1_2_16_152_1 e_1_2_16_201_1 e_1_2_16_190_1 e_1_2_16_224_1 e_1_2_16_24_1 e_1_2_16_47_1 e_1_2_16_139_1 e_1_2_16_85_1 e_1_2_16_62_1 e_1_2_16_116_1 e_1_2_16_142_1 e_1_2_16_188_1 e_1_2_16_165_1 e_1_2_16_214_1 e_1_2_16_180_1 e_1_2_16_12_1 e_1_2_16_35_1 e_1_2_16_58_1 e_1_2_16_104_1 e_1_2_16_96_1 e_1_2_16_73_1 e_1_2_16_50_1 e_1_2_16_127_1 e_1_2_16_199_1 e_1_2_16_153_1 e_1_2_16_176_1 e_1_2_16_6_1 e_1_2_16_130_1 e_1_2_16_202_1 e_1_2_16_225_1 e_1_2_16_191_1 |
References_xml | – volume: S1201‐9712 start-page: 00124 issue: 23 year: 2023 end-page: 8 article-title: Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: a KSGCT multicenter analysis publication-title: Int J Infect Dis – volume: 19 start-page: S167 year: 2013 end-page: S168 article-title: Human rhinovirus RNA detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality publication-title: Biol Blood Marrow Transplant – volume: 9 start-page: 493 issue: 8 year: 2009 end-page: 504 article-title: Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses publication-title: Lancet Infect Dis – volume: 49 start-page: S30 year: 2011 end-page: S33 article-title: The clinical microbiology laboratory in the diagnosis of lower respiratory tract infections publication-title: J Clin Microbiol – volume: 9 start-page: 21 year: 2020 article-title: Infectious complications subcommittee of the Spanish hematopoietic stem cell transplantation and cell therapy group (GETH). Risk factors and outcome of COVID‐19 in patients with hematological malignancies publication-title: Exp Hematol Oncol – volume: 15 start-page: 1143 year: 2009 end-page: 1238 article-title: Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective publication-title: Biol Blood Marrow Transplant – volume: 95 year: 2023 article-title: Nirmatrelvir‐ritonavir for the treatment of COVID‐19 patients: a systematic review and meta‐analysis publication-title: J Med Virol – volume: 108 start-page: 1840 issue: 7 year: 2022 end-page: 1850 article-title: Allogeneic, off‐the‐shelf, SARS‐CoV‐2‐specific T cells (ALVR109) for the treatment of COVID‐19 in high risk patients publication-title: Haematologica – volume: 209 start-page: 1195 issue: 8 year: 2014 end-page: 1204 article-title: Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease publication-title: J Infect Dis – volume: 117 start-page: 5050 issue: 19 year: 2011 end-page: 5056 article-title: Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients publication-title: Blood – volume: 61 start-page: 192 issue: 2 year: 2015 end-page: 202 article-title: Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant publication-title: Clin Infect Dis – volume: 11 issue: 2 year: 2016 article-title: Long‐term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders publication-title: PLoS One – volume: 7 start-page: 53930 year: 2016 end-page: 53940 article-title: Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies publication-title: Oncotarget – volume: 383 start-page: 2586 issue: 26 year: 2020 end-page: 2588 article-title: Shedding of viable SARS‐CoV‐2 after immunosuppressive therapy for cancer publication-title: N Engl J Med – volume: 144 start-page: 344 year: 2006 end-page: 349 article-title: Brief communication: fatal human metapneumovirus infection in stem‐cell transplant recipients publication-title: Ann Intern Med – volume: 55 start-page: 773 year: 2020 end-page: 779 article-title: Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant publication-title: Bone Marrow Transplant – volume: 14 start-page: 267 issue: 2 year: 2022 article-title: Rhinovirus infections among hematopoietic stem cell transplant recipients: a pre‐transplant dilemma? publication-title: Viruses – volume: 141 start-page: 877 issue: 8 year: 2023 end-page: 885 article-title: Banking on virus‐specific T cells to fulfill the need for off‐the‐shelf cell therapies publication-title: Blood – volume: 58 year: 2021 article-title: Early use of nitazoxanide in mild COVID‐19 disease: randomised, placebo‐controlled trial publication-title: Eur Respir J – volume: 13 start-page: 1425 year: 2007 end-page: 1427 article-title: Disseminated bocavirus infection after stem cell transplant publication-title: Emerg Infect Dis – volume: 115 start-page: 2088 issue: 10 year: 2010 end-page: 2094 article-title: Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients publication-title: Blood – volume: 33 start-page: 523 issue: 2 year: 2019 end-page: 544 article-title: Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient publication-title: Infect Dis Clin North Am – volume: 56 start-page: 258 issue: 2 year: 2013 end-page: 266 article-title: Fourth European Conference on Infections in Leukaemia (ECIL‐4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus publication-title: Clin Infect Dis – volume: 24 issue: 2 year: 2022 article-title: Impact of COVID‐19 in hematopoietic stem cell transplant recipients: a systematic review and meta‐analysis publication-title: Transpl Infect Dis – volume: 370 start-page: 358 issue: 2 year: 2016 end-page: 364 article-title: Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review publication-title: Cancer Lett – volume: 11 issue: 1 year: 2021 article-title: Platinum chloride‐based viability RT‐qPCR for SARS‐CoV‐2 detection in complex samples publication-title: Sci Rep – volume: 26 start-page: 782 issue: 4 year: 2020 end-page: 788 article-title: Respiratory viruses cause late morbidity in recipients of hematopoietic stem cell transplantation publication-title: Biol Blood Marrow Transplant – volume: 24 start-page: 2293 issue: 11 year: 2018 end-page: 2301 article-title: Antibiotic exposure prior to respiratory viral infection is associated with progression to lower respiratory tract disease in allogeneic hematopoietic cell transplant recipients publication-title: Biol Blood Marrow Transplant – volume: 22 start-page: 1904 year: 2016 end-page: 1906 article-title: Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplantation patients publication-title: Biol Blood Marrow Transplant – volume: 28 start-page: 479 issue: 5 year: 2001 end-page: 484 article-title: Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation publication-title: Bone Marrow Transplant – volume: 54 start-page: 1058 issue: 7 year: 2019 end-page: 1066 article-title: Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients publication-title: Bone Marrow Transplant – volume: 52 start-page: 1016 year: 2017 end-page: 1021 article-title: A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients publication-title: Bone Marrow Transplant – volume: 40 start-page: 677 year: 2012 end-page: 684 article-title: Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation publication-title: Infection – volume: 73 start-page: e3884 issue: 11 year: 2021 end-page: e3899 article-title: Viral cultures for Coronavirus disease 2019 infectivity assessment: a systematic review publication-title: Clin Infect Dis – volume: 84 start-page: 304 issue: 4 year: 2016 end-page: 308 article-title: Evaluation of a fluorescent immunoassay rapid test (Sofia™) for detection of influenza A+B and RSV in a tertiary pediatric setting publication-title: Diagn Microbiol Infect Dis – volume: 26 start-page: 646 year: 2020 article-title: Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study publication-title: Clin Microbiol Infect – volume: 401 start-page: 281 year: 2023 end-page: 293 article-title: Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID‐19 at increased risk of adverse outcomes (PANORAMIC): an open‐label, platform‐adaptive randomised controlled trial publication-title: Lancet – volume: 24 start-page: 1490 issue: 7 year: 2018 end-page: 1496 article-title: Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing publication-title: Biol Blood Marrow Transplant – volume: 57 start-page: 623 year: 2016 end-page: 627 article-title: Serious outbreak of human metapneumovirus in patients with hematologic malignancies publication-title: Leuk Lymphoma – volume: 398 start-page: 298 issue: 10297 year: 2021 end-page: 299 article-title: Antibody response after second BNT162b2 dose in allogeneic HSCT recipients publication-title: Lancet – volume: 24 start-page: 1055 issue: 10 year: 2018 end-page: 1063 article-title: Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta‐analysis publication-title: Clin Microbiol Infect – volume: 9 start-page: 1197 year: 2021 end-page: 1208 article-title: Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: a systematic review and meta‐analysis publication-title: Immun Inflamm Dis – volume: 42 start-page: 637 issue: 10 year: 2008 end-page: 641 article-title: Influenza vaccination in hematopoietic SCT recipients publication-title: Bone Marrow Transplant – volume: 35 start-page: 2885 issue: 10 year: 2021 end-page: 2894 article-title: COVID‐19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey publication-title: Leukemia – volume: 107 start-page: 1731 issue: 7 year: 2022 end-page: 1735 article-title: Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID‐19 publication-title: Haematologica – volume: 63 start-page: 178 issue: 2 year: 2016 end-page: 185 article-title: Human metapneumovirus infections following hematopoietic cell transplantation: factors associated with disease progression publication-title: Clin Infect Dis – volume: 100 start-page: e285 year: 2015 end-page: e288 article-title: Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma publication-title: Haematologica – volume: 386 start-page: 1615 year: 2022 end-page: 1626 article-title: Prefusion F protein‐based respiratory syncytial virus immunization in pregnancy publication-title: N Engl J Med – volume: 22 issue: 4 year: 2020 article-title: Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation publication-title: Transpl Infect Dis – volume: 158 start-page: 1297 year: 2013 end-page: 1303 article-title: Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season publication-title: Arch Virol – volume: 29 start-page: 528 year: 1999 end-page: 532 article-title: Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients publication-title: Clin Infect Dis – volume: 22 start-page: 209 year: 2022 end-page: 221 article-title: Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID‐19 (DisCoVeRy): a phase 3, randomised, controlled, open‐label trial publication-title: Lancet Infect Dis – volume: 225 start-page: 2056 year: 2022 end-page: 2066 article-title: Phase 1/2 randomized study of the immunogenicity, safety, and tolerability of a respiratory syncytial virus prefusion F vaccine in adults with concomitant inactivated influenza vaccine publication-title: J Infect Dis – volume: 60 issue: 2 year: 2022 article-title: Quantitative SARS‐CoV‐2 viral‐load curves in paired saliva samples and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection publication-title: J Clin Microbiol – volume: 56 start-page: e00367 issue: 7 year: 2018 end-page: e00318 article-title: Detection of influenza A and B viruses and respiratory syncytial virus by use of clinical laboratory improvement amendments of 1988 (CLIA)‐waived point‐of‐care assays: a paradigm shift to molecular tests publication-title: J Clin Microbiol – volume: 195 start-page: E220 year: 2023 end-page: E226 article-title: Population‐based evaluation of the effectiveness of nirmatrelvir‐ritonavir for reducing hospital admissions and mortality from COVID‐19 publication-title: Randomized Controlled Trial – volume: 80 start-page: 333 issue: 3 year: 2020 end-page: 341 article-title: The clinical benefit of instituting a prospective clinical community‐acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation publication-title: J Infect – volume: 385 start-page: 562 issue: 6 year: 2021 end-page: 566 article-title: SARS‐CoV‐2 variants in patients with immunosuppression publication-title: N Engl J Med – volume: 27 start-page: 472 issue: 3 year: 2021 article-title: Field evaluation of a rapid antigen test (Panbio™ COVID‐19 Ag Rapid Test Device) for COVID‐19 diagnosis in primary healthcare centres publication-title: Clin Microbiol Infect – volume: 40 start-page: 343 year: 2022 end-page: 345 article-title: Impact of COVID‐19 on case fatality rate of patients with cancer during the omicron wave publication-title: Cancer Cell – volume: 216 start-page: 678 issue: 6 year: 2017 end-page: 687 article-title: Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy publication-title: J Infect Dis – volume: 68 start-page: 1641 issue: 10 year: 2019 end-page: 1649 article-title: Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients publication-title: Clin Infect Dis – volume: 62 start-page: e00766 year: 2018 end-page: 18 article-title: Orally efficacious broad‐spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses publication-title: Antimicrob Agents Chemother – volume: 13 start-page: 8 issue: 1 year: 2023 article-title: One‐year breakthrough SARS‐CoV‐2 infection and correlates of protection in fully vaccinated hematological patients publication-title: Blood Cancer J – volume: 5 start-page: 1903 issue: 7 year: 2021 end-page: 1914 article-title: Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation publication-title: Blood Adv – volume: 30 start-page: 277 issue: 1 year: 2017 end-page: 319 article-title: Respiratory syncytial virus: infection, detection, and new options for prevention and treatment publication-title: Clin Microbiol Rev – volume: 9 start-page: 2478 year: 2018 article-title: Laboratory diagnosis of respiratory tract infections in children‐the state of the art publication-title: Front Microbiol – volume: 57 start-page: 649 issue: 4 year: 2022 end-page: 657 article-title: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients publication-title: Bone Marrow Transplant – volume: 8 start-page: 613 year: 2019 end-page: 626 article-title: Safety, resistance, and efficacy results from a phase IIIb study of conventional‐ and double‐dose oseltamivir regimens for treatment of influenza in immunocompromised patients publication-title: Infect Dis Ther – volume: 53 start-page: 3738 year: 2015 end-page: 3749 article-title: Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta‐analysis publication-title: J Clin Microbiol – volume: 123 start-page: 3263 issue: 21 year: 2014 end-page: 3268 article-title: Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections publication-title: Blood – volume: 67 start-page: 813 issue: 6 year: 2018 end-page: 816 article-title: A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology publication-title: Clin Infect Dis – volume: 57 start-page: 1731 year: 2013 end-page: 1741 article-title: Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes publication-title: Clin Infect Dis – year: 2023 article-title: Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2‐reactive antibody waning, booster effect and breakthrough SARS‐CoV‐2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination publication-title: Bone Marrow Transplant – volume: 15 start-page: 474 issue: 5 year: 2013 end-page: 486 article-title: Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients publication-title: Transpl Infect Dis – volume: 22 start-page: 380 issue: 4 year: 2016 article-title: Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy publication-title: Clin Microbiol Infect – volume: 27 start-page: 1826 year: 2021 end-page: 1837 article-title: An open‐label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN‐β‐1a and hydroxychloroquine in hospitalized patients with COVID‐19 publication-title: Clin Microbiol Infect – volume: 19 year: 2017 article-title: A risk‐adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: a pilot study publication-title: Transpl Infect Dis – volume: 55 start-page: 431 issue: 2 year: 2020 end-page: 440 article-title: The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey publication-title: Bone Marrow Transplant – volume: 14 start-page: 555 issue: 6 year: 2012 end-page: 563 article-title: Fourth European Conference on Infections in Leukemia. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011) publication-title: Transpl Infect Dis – volume: 22 issue: 6 year: 2020 article-title: Detection of community‐acquired respiratory viruses in allogeneic stem‐cell transplant recipients and controls‐a prospective cohort study publication-title: Transpl Infect Dis – volume: 22 start-page: 542 year: 2016 end-page: 548 article-title: Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring index publication-title: Biol Blood Marrow Transplant – volume: 28 start-page: 810 issue: 12 year: 2022 end-page: 821 article-title: Revised guidelines for Coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022) publication-title: Transplant Cell Ther – volume: 36 start-page: 1523 year: 2003 end-page: 1532 article-title: Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double‐blind, randomized, placebo‐controlled trials publication-title: Clin Infect Dis – volume: 19 start-page: 1220 issue: 8 year: 2013 end-page: 1226 article-title: Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients publication-title: Biol Blood Marrow Transplant – volume: 64 start-page: 1532 year: 2017 end-page: 1539 article-title: Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies publication-title: Clin Infect Dis – volume: 56 start-page: 2212 issue: 9 year: 2021 end-page: 2220 article-title: Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS‐COV‐2 pandemic publication-title: Bone Marrow Transplant – volume: 67 issue: 1 year: 2023 article-title: A double‐blind, randomized, placebo‐controlled, phase II clinical study to evaluate the efficacy and safety of camostat mesylate (DWJ1248) in adult patients with mild to moderate COVID‐19 publication-title: Antimicrob Agents Chemother – volume: 35 start-page: S73 issue: 1 year: 2005 end-page: S76 article-title: Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity publication-title: Bone Marrow Transplant – volume: 60 start-page: 85 year: 2019 end-page: 91 article-title: Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)‐infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab publication-title: Leuk Lymphoma – volume: 225 start-page: 1482 year: 2022 end-page: 1493 article-title: Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant patients publication-title: J Infect Dis – volume: 81 start-page: 1498 issue: 8 year: 2009 end-page: 1507 article-title: Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients publication-title: J Med Virol – volume: 28 start-page: 222 year: 2022 end-page: 238 article-title: ESCMID COVID‐19 living guidelines: drug treatment and clinical management publication-title: Clin Microbiol Infect – volume: 14 start-page: 609 year: 2014 end-page: 618 article-title: Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double‐blind, randomised, placebo‐controlled, phase 2b/3 trial publication-title: Lancet Infect Dis – year: 2023 article-title: Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation publication-title: J Infect Dis – volume: 399 start-page: 1941 year: 2022 end-page: 1953 article-title: Remdesivir and three other drugs for hospitalised patients with COVID‐19: final results of the WHO Solidarity randomised trial and updated meta‐analyses publication-title: Lancet – volume: 40 start-page: 699 year: 2007 end-page: 700 article-title: Human metapneumovirus infection in a hematopoietic transplant recipient publication-title: Bone Marrow Transplant – volume: 223 start-page: 1564 issue: 9 year: 2021 end-page: 1575 article-title: Seasonal human coronavirus respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation publication-title: J Infect Dis – volume: 30 start-page: 82 year: 2011 end-page: 84 article-title: Persistence of human bocavirus DNA in immunocompromised children publication-title: Pediatr Infect Dis J – volume: 11 start-page: 100 year: 2009; end-page: 105 article-title: Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation publication-title: Transpl Infect Dis – volume: 85 start-page: 278 issue: 5 year: 2006 end-page: 287 article-title: Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center publication-title: Medicine (Baltimore) – volume: 57 start-page: 1765 issue: 12 year: 2022 end-page: 1773 article-title: Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant publication-title: Bone Marrow Transplant – volume: 68 start-page: 1 year: 2015 end-page: 5 article-title: The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients publication-title: J Clin Virol – volume: 55 start-page: 715 year: 2017 end-page: 723 article-title: Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship publication-title: J Clin Microbiol – volume: 44 start-page: 749 issue: 11 year: 2009 end-page: 756 article-title: Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced‐intensity allogeneic hematopoietic SCT publication-title: Bone Marrow Transplant – volume: 24 start-page: 563 issue: 3 year: 2018 end-page: 570 article-title: Epidemiologic and clinical characteristics of coronavirus and bocavirus respiratory infections after allogeneic stem cell transplantation: a prospective single center study publication-title: Biol Blood Marrow Transplant – volume: 1 year: 2023 article-title: Remdesivir for the treatment of COVID‐19 publication-title: Cochrane Database Syst Rev – year: 2020 – volume: 91 start-page: e01659 issue: 7 year: 2017 end-page: 16 article-title: Human rhinovirus diversity and evolution: how strange the change from major to minor publication-title: J Virol – volume: 20 issue: 4 year: 2018 article-title: Community‐acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: risk factors and mortality from pulmonary virus‐bacterial mixed infections publication-title: Transpl Infect Dis – volume: 24 start-page: 333 issue: 4 year: 2011 end-page: 343 article-title: Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients publication-title: Curr Opin Infect Dis – volume: 382 start-page: 1787 year: 2020 end-page: 1799 article-title: A trial of lopinavir‐ritonavir in adults hospitalized with severe Covid‐19 publication-title: N Engl J Med – volume: 35 issue: 3 year: 2022 article-title: Digital PCR applications in the SARS‐CoV‐2/COVID‐19 era: a roadmap for future outbreaks publication-title: Clin Microbiol Rev – volume: 206 start-page: 1872 issue: 12 year: 2012 end-page: 1877 article-title: Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients publication-title: J Infect Dis – volume: 97 start-page: 30 issue: 1 year: 2022 end-page: 42 article-title: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group publication-title: Am J Hematol – volume: 39 start-page: 801 year: 2001 end-page: 803 article-title: Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit publication-title: J Clin Microbiol – volume: 216 start-page: 203 year: 2017 end-page: 209 article-title: Prolonged shedding of human coronavirus in hematopoietic cell transplant recipients: risk factors and viral genome evolution publication-title: J Infect Dis – volume: 379 start-page: 100 issue: 1 year: 2016 end-page: 106 article-title: Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review publication-title: Cancer Lett – volume: 57 start-page: 1731 issue: 12 year: 2013 end-page: 1741 article-title: Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes publication-title: Clin Infect Dis – volume: 115 start-page: 1331 issue: 7 year: 2010 end-page: 1342 article-title: How I treat influenza in patients with hematologic malignancies publication-title: Blood – volume: 56 start-page: 3032 year: 2021 end-page: 3041 article-title: Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients publication-title: Bone Marrow Transplant – volume: 396 start-page: 1345 issue: 10259 year: 2020 end-page: 1352 article-title: Lopinavir‐ritonavir in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial publication-title: Lancet – volume: 15 start-page: 54 issue: 1 year: 2022 article-title: Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). SARS‐CoV‐2 vaccine response and rate of breakthrough infection in patients with hematological disorders publication-title: J Hematol Oncol – volume: 9 start-page: 1407 year: 2021 end-page: 1418 article-title: Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID‐19 (COV‐BARRIER): a randomised, double‐blind, parallel‐group, placebo‐controlled phase 3 trial publication-title: Lancet Respir Med – volume: S2213‐2600 start-page: 00412 issue: 22 year: 2022 end-page: X article-title: Favipiravir in patients hospitalised with COVID‐19 (PIONEER trial): a multicentre, open‐label, phase 3, randomised controlled trial of early intervention versus standard care publication-title: Lancet Respir Med – volume: 17 start-page: 566 issue: 4 year: 2011 end-page: 573 article-title: Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers’ experiences publication-title: Biol Blood Marrow Transplant – volume: 195 start-page: 194 issue: 2 year: 2021 end-page: 197 article-title: Reduction in incidence of non‐COVID‐19 respiratory virus infection amongst haematology inpatients following UK social distancing measures publication-title: Br J Haematol – volume: 103 start-page: 1611 year: 2004 end-page: 1617 article-title: The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management publication-title: Blood – volume: 24 start-page: 4847 issue: 5 year: 2023 article-title: Comparison of SARS‐CoV‐2 detection in nasopharyngeal swab and saliva samples from patients infected with Omicron variant publication-title: Int J Mol Sci – volume: 5 year: 2018 article-title: Community‐acquired respiratory paramyxovirus infection after allogeneic hematopoietic cell transplantation: a single‐center experience publication-title: Open Forum Infect Dis – volume: 46 start-page: 402 issue: 3 year: 2008 end-page: 412 article-title: Respiratory syncytial virus infection in patients with hematological diseases: single‐center study and review of the literature publication-title: Clin Infect Dis – volume: 110 start-page: 1681 year: 2007 end-page: 1688 article-title: Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection publication-title: Blood – volume: 25 start-page: 163 issue: 1 year: 2019 end-page: 171 article-title: Risk factors for parainfluenza virus lower respiratory tract disease after hematopoietic cell transplantation publication-title: Biol Blood Marrow Transplant – volume: 90 start-page: 413 year: 2013 end-page: 419 article-title: Adjuvanted influenza A (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy‐treated patients publication-title: Eur J Haematol – volume: 39 start-page: 1300 issue: 9 year: 2004 end-page: 1306 article-title: Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy publication-title: Clin Infect Dis – volume: 2 start-page: 203 year: 2012 end-page: 218 article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients publication-title: Am J Blood Res – volume: 48 start-page: 1548 year: 2013 end-page: 1553 article-title: Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit publication-title: Bone Marrow Transplant – volume: 71 start-page: 109 issue: 2 year: 2018 end-page: 115 article-title: Human parainfluenza virus type 3 infections in patients with hematopoietic stem cell transplants: the mode of nosocomial infections and prognosis publication-title: Jpn J Infect Dis – volume: 119 start-page: 2738 issue: 12 year: 2012 end-page: 2745 article-title: The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation publication-title: Blood – volume: 388 start-page: 406 year: 2023 end-page: 417 article-title: VV116 versus nirmatrelvir‐ritonavir for oral treatment of Covid‐19 publication-title: N Engl J Med – volume: 23 issue: 4 year: 2021 article-title: Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: a viable strategy for COVID‐19 immunosuppressed patients? publication-title: Transpl Infect Dis – volume: 105 start-page: 235 issue: 1 year: 2020 end-page: 243 article-title: Rapid generation of multivirus‐specific T lymphocytes for the prevention and treatment of respiratory viral infections publication-title: Haematologica – volume: 26 start-page: 323 issue: 3 year: 2022 end-page: 331 article-title: Clinical Performance of the cobas Liat SARS‐CoV‐2 & influenza A/B assay in nasal samples publication-title: Mol Diagn Ther – volume: 384 start-page: 905 year: 2021 end-page: 914 article-title: A neutralizing monoclonal antibody for hospitalized patients with Covid‐19 publication-title: N Engl J Med – volume: 112 start-page: 1191 year: 2022 end-page: 1200 article-title: Recommendations for the management of drug‐drug interactions between the COVID‐19 antiviral nirmatrelvir/ritonavir (paxlovid) and comedications publication-title: Clin Pharmacol Ther – volume: 22 year: 2020 article-title: Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes publication-title: Transpl Infect Dis – volume: 13 start-page: 1665 year: 2021 article-title: Antiviral activity of umifenovir in vitro against a broad spectrum of coronaviruses, including the novel SARS‐CoV‐2 virus publication-title: Viruses – volume: 57 start-page: 1807 issue: 8 year: 2016 end-page: 1813 article-title: Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment publication-title: Leuk Lymphoma – volume: 6 start-page: 5307 issue: 18 year: 2022 end-page: 5316 article-title: Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes publication-title: Blood Adv – volume: 384 start-page: 795 year: 2021 end-page: 807 article-title: Baricitinib plus remdesivir for hospitalized adults with Covid‐19 publication-title: N Engl J Med – volume: 20 start-page: 1204 year: 2020 end-page: 1214 article-title: Early treatment with baloxavir marboxil in high‐risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE‐2): a randomised, placebo‐controlled, phase 3 trial publication-title: Lancet Infect Dis – volume: 386 start-page: 509 year: 2022 end-page: 520 article-title: Molnupiravir for oral treatment of Covid‐19 in nonhospitalized patients publication-title: N Engl J Med – volume: 75 start-page: 1883 year: 2022 end-page: 1892 article-title: Favipiravir for treatment of outpatients with asymptomatic or uncomplicated Coronavirus disease 2019: a double‐blind, randomized, placebo‐controlled, phase 2 trial publication-title: Clin Infect Dis – volume: 192 start-page: 1061 year: 2005 end-page: 1065 article-title: A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections publication-title: J Infect Dis – volume: 55 start-page: 2261 issue: 12 year: 2020 end-page: 2269 article-title: Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation publication-title: Bone Marrow Transplant – volume: 102 start-page: 1120 year: 2017 end-page: 1130 article-title: Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality publication-title: Haematologica – volume: 16 start-page: 192 issue: 2 year: 2010 end-page: 198 article-title: Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients publication-title: Biol Blood Marrow Transplant – volume: 17 start-page: 979 issue: 7 year: 2011 end-page: 986 article-title: Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus publication-title: Biol Blood Marrow Transplant – volume: 5 start-page: 135 year: 2017 end-page: 146 article-title: Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double‐blind, double‐dummy, phase 3 trial publication-title: Lancet Respir Med – volume: 19 start-page: 589 year: 2013 end-page: 596 article-title: Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement publication-title: Biol Blood Marrow Transplant – volume: 10 issue: 3 year: 2022 article-title: Detectable duration of viable SARS‐CoV‐2, total and subgenomic SARS‐CoV‐2 RNA in noncritically Ill COVID‐19 patients: a prospective cohort study publication-title: Microbiol Spectr – volume: 47 start-page: 867 year: 2021 end-page: 886 article-title: Lopinavir‐ritonavir and hydroxychloroquine for critically ill patients with COVID‐19: REMAP‐CAP randomized controlled trial publication-title: Intensive Care Med – volume: 104 start-page: 1322 issue: 7 year: 2019 end-page: 1331 article-title: Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies publication-title: Haematologica – volume: 68 start-page: 1894 issue: 11 year: 2019 end-page: 1903 article-title: Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: a cross‐sectional, prospective, observational study publication-title: Clin Infect Dis – volume: 26 start-page: 862 year: 2007 end-page: 864 article-title: Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin publication-title: J Heart Lung Transplant – volume: 19 start-page: e200 issue: 6 year: 2019 end-page: e212 article-title: European Conference on Infections in Leukaemia group. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) publication-title: Lancet Infect Dis – volume: 383 start-page: 2291 year: 2020 end-page: 2293 article-title: Persistence and evolution of SARS‐CoV‐2 in an immunocompromised host publication-title: N Engl J Med – volume: 51 start-page: 155 year: 2013 end-page: 162 article-title: Molecular characterization of a respiratory syncytial virus (RSV) outbreak in a hematology unit, Heidelberg, Germany publication-title: J Clin Microbiol – volume: 47 start-page: 132 issue: 3 year: 2021 end-page: 138 article-title: Seasonality of coronaviruses and other respiratory viruses in Canada: implications for COVID‐19 publication-title: Can Commun Dis Rep – volume: 32 issue: 5 year: 2022 article-title: Detection of respiratory viruses directly from clinical samples using next‐generation sequencing: a literature review of recent advances and potential for routine clinical use publication-title: Rev Med Virol – volume: 20 start-page: 342 issue: 1 year: 2022 article-title: A multicenter, double‐blind, randomized, parallel‐group, placebo‐controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID‐19 (CANDLE study) publication-title: BMC Med – volume: 53 start-page: 3738 issue: 12 year: 2015 end-page: 3749 article-title: Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta‐analysis publication-title: J Clin Microbiol – volume: 21 issue: 5 year: 2019 article-title: Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients publication-title: Transpl Infect Dis – volume: 18 start-page: 148 issue: 3 year: 2023 end-page: 156 article-title: The origins of new SARS‐COV‐2 variants in immuncompromised individuals publication-title: Curr Opin HIV AIDS – volume: 188 start-page: 560 issue: 4 year: 2020 end-page: 569 article-title: Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant‐related mortality publication-title: Br J Haematol – volume: 36 start-page: 1 issue: 1 year: 2003 end-page: 8 article-title: Respiratory virus infections in adults with hematologic malignancies: a prospective study publication-title: Clin Infect Dis – volume: 11 year: 2021 article-title: Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models publication-title: Sci Rep – volume: 12 year: 2021 article-title: Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID‐19 patients: a prospective, multicenter, open‐label, randomized controlled clinical trial publication-title: Front Pharmacol – volume: 219 start-page: 1026 year: 2019 end-page: 1034 article-title: Phase 2b Study of Pimodivir (JNJ‐63623872) as monotherapy or in combination with oseltamivir for treatment of acute uncomplicated seasonal influenza A: TOPAZ trial publication-title: J Infect Dis – volume: 16 start-page: 165 issue: 1 year: 2014 end-page: 169 article-title: Prolonged respiratory viral shedding in transplant patients publication-title: Transpl Infect Dis – volume: 216 start-page: 153 issue: 2 year: 2017 end-page: 161 article-title: Characterizing the cellular immune response to parainfluenza virus 3 publication-title: J Infect Dis – volume: 16 start-page: 132 year: 2016 end-page: 142 article-title: Human influenza viruses and CD8(+) T cell responses publication-title: Curr Opin Virol – volume: 28 start-page: 51 year: 2001 end-page: 57 article-title: Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study publication-title: Bone Marrow Transplant – volume: 15 start-page: 474 year: 2013 end-page: 486 article-title: Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients publication-title: Transpl Infect Dis – volume: 15 start-page: 219 issue: 3 year: 2013 end-page: 232 article-title: European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL‐4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN publication-title: Transpl Infect Dis – volume: 145 start-page: 667 year: 2009 end-page: 669 article-title: Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin publication-title: Br J Haematol – volume: 38 start-page: 29 issue: 1 year: 2017 end-page: 36 article-title: Respiratory syncytial virus infection: an illness for all ages publication-title: Clin Chest Med – year: 2022 article-title: Breakthrough COVID‐19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey publication-title: Blood – volume: 168 start-page: 208 year: 2003 end-page: 214 article-title: Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation publication-title: Am J Respir Crit Care Med – volume: 88 start-page: 11760 issue: 20 year: 2014 end-page: 11773 article-title: Immunodominant CD4+ T‐cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein publication-title: J Virol – volume: 73 start-page: 2073 issue: 11 year: 2021 end-page: 2082 article-title: Vaccinated and convalescent donor‐derived severe acute respiratory syndrome Coronavirus 2‐specific T cells as adoptive immunotherapy for high‐risk Coronavirus disease 2019 patients publication-title: Clin Infect Dis – volume: 19 start-page: 387 year: 2013 end-page: 392 article-title: Adenovirus viremia and disease: comparison of T cell‐depleted and conventional hematopoietic stem cell transplantation recipients from a single institution publication-title: Biol Blood Marrow Transplant – volume: 150‐151 year: 2022 article-title: Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients publication-title: J Clin Virol – volume: 24 start-page: 2160 issue: 10 year: 2018 end-page: 2163 article-title: Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients publication-title: Biol Blood Marrow Transplant – volume: 16 start-page: 756 issue: 4 year: 2022 end-page: 766 article-title: Prevalence and seasonality of viral respiratory infections in a temperate climate region: a 24‐year study (1997‐2020) publication-title: Influenza Other Respir Viruses – volume: 25 start-page: 800 year: 2019 end-page: 809 article-title: Pulmonary Impairment after respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients publication-title: Biol Blood Marrow Transplant – volume: 15 start-page: 27 year: 2022 article-title: Determinants of SARS‐CoV‐2 waning immunity in allogeneic hematopoietic stem cell transplant recipients publication-title: J Hematol Oncol – volume: 25 start-page: 1011 issue: 5 year: 2019 end-page: 1021 article-title: Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection publication-title: Biol Blood Marrow Transplant – volume: 16 start-page: 782 issue: 6 year: 2010 end-page: 791 article-title: Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life‐threatening acute and chronic alloimmune lung syndromes publication-title: Biol Blood Marrow Transplant – volume: 134 start-page: 64 issue: 1 year: 2006 end-page: 76 article-title: Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation publication-title: Br J Haematol – volume: 9 start-page: 678 year: 2018 article-title: The CD8 T cell response to respiratory virus infections publication-title: Front Immunol – volume: 68 start-page: 895 year: 2019 end-page: 902 article-title: Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa publication-title: Clin Infect Dis – volume: 27 start-page: 441 year: 2014 end-page: 462 article-title: Adenovirus infections in immunocompetent and immunocompromised patients publication-title: Clin Microbiol Rev – volume: 98 start-page: 573 year: 2001 end-page: 578 article-title: Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome publication-title: Blood – volume: 7 start-page: 1161 year: 2022 end-page: 1179 article-title: SARS‐CoV‐2 Omicron is an immune escape variant with an altered cell entry pathway publication-title: Nat Microbiol – volume: 76 start-page: iii58 year: 2021 end-page: iii66 article-title: A discussion of syndromic molecular testing for clinical care publication-title: J Antimicrob Chemother – volume: 226 start-page: 1790 year: 2022 end-page: 1799 article-title: Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double‐blind, placebo‐controlled trials publication-title: J Infect Dis – volume: 76 start-page: iii4 year: 2021 end-page: iii11 article-title: Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases publication-title: J Antimicrob Chemother – volume: 193 start-page: 1619 issue: 12 year: 2006 end-page: 1625 article-title: Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses publication-title: J Infect Dis – volume: 73 start-page: e4392 issue: 11 year: 2021 end-page: e4399 article-title: Role of human bocavirus respiratory tract infection in hematopoietic cell transplant recipients publication-title: Clin Infect Dis – volume: 98 start-page: 573 issue: 3 year: 2001 end-page: 578 article-title: Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome publication-title: Blood – volume: 174 start-page: 1392 issue: 12 year: 2006 end-page: 1399 article-title: Chronic rhinoviral infection in lung transplant recipients publication-title: Am J Respir Crit Care Med – volume: 68 start-page: 1872 year: 2013 end-page: 1880 article-title: Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections publication-title: J Antimicrob Chemother – volume: 221 start-page: 1688 year: 2020 end-page: 1698 article-title: Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically Ill patients with influenza virus infection publication-title: J Infect Dis – volume: 28 start-page: 1203 year: 2022 end-page: 1210 article-title: Remdesivir for the treatment of COVID‐19: a systematic review and meta‐analysis publication-title: Clin Microbiol Infect – volume: 33 start-page: 425 issue: 4 year: 2004 end-page: 430 article-title: Enterovirus infections following T‐cell depleted allogeneic transplants in adults publication-title: Bone Marrow Transplant – volume: 17 issue: 7 year: 2022 article-title: Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: analysis of clinical characteristics, nosocomial transmission and viral shedding publication-title: PLoS One – volume: 59 start-page: S344 issue: 5 year: 2014 end-page: S351 article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies publication-title: Clin Infect Dis – volume: 10 start-page: 1856 issue: 9 year: 2022 article-title: Respiratory tract infections and laboratory diagnostic methods: a review with a focus on syndromic panel‐based assays publication-title: Microorganisms – volume: 18 start-page: 1580 year: 2012 end-page: 1588 article-title: Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time publication-title: Biol Blood Marrow Transplant – volume: 100 start-page: 1619 year: 2002 end-page: 1627 article-title: Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery publication-title: Blood – volume: 138 start-page: 301 issue: 1 year: 2021 article-title: Multicenter, open‐label, phase 3 study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant recipients with Epstein‐Barr virus‐driven post transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE) publication-title: Blood – volume: 140 start-page: 5096 year: 2022 end-page: 5097 article-title: The trend of respiratory virus infection in allogeneic bone marrow transplant recipients during the COVID pandemic publication-title: Blood – volume: 50 start-page: 1061 year: 2012 end-page: 1063 article-title: Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza publication-title: J Clin Microbiol – volume: 11 start-page: 781 issue: 10 year: 2005 end-page: 96 article-title: Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies publication-title: Biol Blood Marrow Transplant – volume: 14 year: 2023 article-title: Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID‐19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry publication-title: Front Immunol – volume: 58 start-page: 1357 year: 2014 end-page: 1368 article-title: Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome publication-title: Clin Infect Dis – volume: 39 start-page: 673 year: 2004 end-page: 680 article-title: Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation publication-title: Clin Infect Dis – ident: e_1_2_16_126_1 doi: 10.1016/S0140-6736(22)02597-1 – ident: e_1_2_16_20_1 doi: 10.1128/JCM.00789-11 – ident: e_1_2_16_64_1 doi: 10.1097/01.md.0000232560.22098.4e – ident: e_1_2_16_153_1 doi: 10.1093/jac/dkt111 – ident: e_1_2_16_48_1 doi: 10.1016/j.bbmt.2009.06.019 – ident: e_1_2_16_33_1 doi: 10.1016/j.cmi.2020.11.004 – ident: e_1_2_16_218_1 doi: 10.1016/j.ccm.2016.11.010 – ident: e_1_2_16_97_1 doi: 10.1371/journal.pone.0271756 – ident: e_1_2_16_75_1 doi: 10.1016/j.bbmt.2012.12.019 – ident: e_1_2_16_46_1 doi: 10.1086/598627 – volume: 195 start-page: E220 year: 2023 ident: e_1_2_16_131_1 article-title: Population‐based evaluation of the effectiveness of nirmatrelvir‐ritonavir for reducing hospital admissions and mortality from COVID‐19 publication-title: Randomized Controlled Trial – ident: e_1_2_16_36_1 doi: 10.1093/cid/ciy584 – ident: e_1_2_16_58_1 doi: 10.1016/j.bbmt.2018.08.021 – ident: e_1_2_16_116_1 doi: 10.1093/infdis/jiz656 – ident: e_1_2_16_61_1 doi: 10.1093/cid/cit639 – ident: e_1_2_16_171_1 doi: 10.1016/j.canlet.2016.05.035 – ident: e_1_2_16_9_1 doi: 10.1097/COH.0000000000000794 – ident: e_1_2_16_127_1 doi: 10.1128/AAC.00766-18 – ident: e_1_2_16_180_1 doi: 10.1002/ajh.26385 – ident: e_1_2_16_194_1 doi: 10.1182/blood-2002-02-0377 – ident: e_1_2_16_39_1 doi: 10.1128/jcm.01785-21 – ident: e_1_2_16_91_1 doi: 10.1164/rccm.200212‐1468OC – ident: e_1_2_16_117_1 doi: 10.1016/S2213‐2600(22)00412‐X – ident: e_1_2_16_121_1 doi: 10.1056/NEJMoa2001282 – ident: e_1_2_16_144_1 doi: 10.1111/tid.13276 – ident: e_1_2_16_152_1 doi: 10.3324/haematol.2018.215152 – ident: e_1_2_16_38_1 doi: 10.3390/ijms24054847 – ident: e_1_2_16_167_1 doi: 10.1016/j.canlet.2015.11.014 – ident: e_1_2_16_85_1 doi: 10.1111/tid.13301 – ident: e_1_2_16_139_1 doi: 10.1016/S0140-6736(22)00519-0 – ident: e_1_2_16_57_1 doi: 10.1016/j.bbmt.2013.05.005 – ident: e_1_2_16_56_1 doi: 10.1093/cid/ciu623 – ident: e_1_2_16_128_1 doi: 10.1056/NEJMoa2208822 – ident: e_1_2_16_25_1 doi: 10.1128/JCM.00367-18 – ident: e_1_2_16_80_1 doi: 10.7883/yoken.JJID.2017.424 – ident: e_1_2_16_136_1 doi: 10.1016/j.bbmt.2016.07.005 – ident: e_1_2_16_93_1 doi: 10.1182/blood‐2010‐11‐319186 – ident: e_1_2_16_120_1 doi: 10.1038/s41598-021-02972-y – ident: e_1_2_16_148_1 doi: 10.1016/S2213-2600(16)30435-0 – ident: e_1_2_16_211_1 doi: 10.18632/oncotarget.10182 – ident: e_1_2_16_70_1 doi: 10.1016/j.bbmt.2015.11.015 – ident: e_1_2_16_108_1 doi: 10.1016/j.cmi.2021.11.007 – ident: e_1_2_16_182_1 doi: 10.1186/s13045-022-01250-2 – ident: e_1_2_16_15_1 doi: 10.1086/344899 – ident: e_1_2_16_104_1 doi: 10.1164/rccm.200604-489OC – ident: e_1_2_16_92_1 doi: 10.1093/cid/ciy760 – ident: e_1_2_16_190_1 doi: 10.1128/CMR.00116-13 – ident: e_1_2_16_130_1 doi: 10.1002/cpt.2646 – ident: e_1_2_16_10_1 doi: 10.1111/tid.13415 – ident: e_1_2_16_132_1 doi: 10.1016/S1473-3099(14)70717-0 – ident: e_1_2_16_205_1 doi: 10.1016/j.cmi.2015.12.012 – ident: e_1_2_16_231_1 doi: 10.3324/haematol.2014.116772 – ident: e_1_2_16_50_1 doi: 10.1111/bjh.16216 – ident: e_1_2_16_16_1 doi: 10.1016/j.bbmt.2005.07.007 – ident: e_1_2_16_122_1 doi: 10.1016/S0140-6736(20)32013-4 – ident: e_1_2_16_160_1 doi: 10.1038/bmt.2008.264 – ident: e_1_2_16_208_1 doi: 10.1016/j.bbmt.2019.12.724 – ident: e_1_2_16_178_1 doi: 10.1038/s41375-021-01302-5 – ident: e_1_2_16_32_1 doi: 10.1093/cid/ciaa1764 – ident: e_1_2_16_84_1 doi: 10.1038/s41375‐021‐01302‐5 – ident: e_1_2_16_103_1 doi: 10.1002/jmv.21548 – ident: e_1_2_16_12_1 doi: 10.1093/infdis/jiaa553 – ident: e_1_2_16_215_1 doi: 10.1182/blood‐2021‐147274 – ident: e_1_2_16_162_1 doi: 10.1016/j.bbmt.2010.07.018 – ident: e_1_2_16_8_1 doi: 10.1056/NEJMsb2104756 – ident: e_1_2_16_74_1 doi: 10.1016/j.bbmt.2012.04.012 – ident: e_1_2_16_234_1 doi: 10.1038/bmt.2017.24 – ident: e_1_2_16_60_1 doi: 10.1093/cid/ciw284 – ident: e_1_2_16_141_1 doi: 10.1056/NEJMoa2031994 – ident: e_1_2_16_23_1 doi: 10.3389/fmicb.2018.02478 – ident: e_1_2_16_99_1 doi: 10.1182/bloodadvances.2020003865 – ident: e_1_2_16_201_1 doi: 10.1371/journal.pone.0148258 – ident: e_1_2_16_184_1 doi: 10.1038/s41408-022-00778-3 – ident: e_1_2_16_59_1 doi: 10.1038/sj.bmt.1703139 – ident: e_1_2_16_147_1 doi: 10.1002/iid3.502 – ident: e_1_2_16_30_1 doi: 10.1093/jac/dkab243 – ident: e_1_2_16_135_1 doi: 10.1080/10428194.2018.1468896 – ident: e_1_2_16_52_1 doi: 10.3390/v14020267 – ident: e_1_2_16_196_1 doi: 10.1093/cid/ciaa1149 – ident: e_1_2_16_137_1 doi: 10.1093/infdis/jiy547 – ident: e_1_2_16_114_1 doi: 10.1016/j.cmi.2019.10.012 – ident: e_1_2_16_49_1 doi: 10.1086/422994 – ident: e_1_2_16_202_1 doi: 10.1128/JCM.02151‐12 – ident: e_1_2_16_224_1 doi: 10.3324/haematol.2022.281946 – ident: e_1_2_16_73_1 doi: 10.1038/bmt.2013.94 – ident: e_1_2_16_24_1 doi: 10.3390/microorganisms10091856 – ident: e_1_2_16_81_1 doi: 10.1016/j.bbmt.2009.09.014 – ident: e_1_2_16_133_1 doi: 10.1183/13993003.03725-2020 – ident: e_1_2_16_222_1 doi: 10.1093/cid/ciab371 – ident: e_1_2_16_204_1 doi: 10.1007/s00705‐013‐1610‐1 – ident: e_1_2_16_28_1 doi: 10.1128/JCM.02264-16 – ident: e_1_2_16_3_1 doi: 10.1186/s40164‐020‐00177‐z – ident: e_1_2_16_193_1 doi: 10.1038/sj.bmt.1703083 – ident: e_1_2_16_54_1 doi: 10.1016/j.jtct.2022.09.002 – ident: e_1_2_16_118_1 doi: 10.1093/cid/ciac312 – ident: e_1_2_16_55_1 doi: 10.1093/cid/cit639 – ident: e_1_2_16_232_1 doi: 10.1093/infdis/jiab391 – ident: e_1_2_16_170_1 doi: 10.1111/irv.12972 – ident: e_1_2_16_216_1 doi: 10.1016/j.coviro.2016.01.016 – ident: e_1_2_16_125_1 doi: 10.1056/NEJMoa2116044 – ident: e_1_2_16_212_1 doi: 10.1111/tid.13158 – ident: e_1_2_16_210_1 doi: 10.1182/blood.V98.3.573 – ident: e_1_2_16_119_1 doi: 10.3389/fphar.2021.683296 – ident: e_1_2_16_229_1 doi: 10.1038/s41564-022-01143-7 – ident: e_1_2_16_5_1 doi: 10.1111/bjh.17651 – ident: e_1_2_16_168_1 doi: 10.1086/432732 – ident: e_1_2_16_143_1 doi: 10.1016/S1473-3099(21)00485-0 – ident: e_1_2_16_233_1 doi: 10.1038/s41409-019-0728-5 – ident: e_1_2_16_198_1 doi: 10.1097/INF.0b013e3181f12fcf – ident: e_1_2_16_154_1 doi: 10.1086/525263 – ident: e_1_2_16_220_1 doi: 10.1093/infdis/jix358 – ident: e_1_2_16_66_1 doi: 10.1038/s41409‐019‐0698‐7 – ident: e_1_2_16_18_1 doi: 10.1016/j.bbmt.2017.11.001 – ident: e_1_2_16_2_1 doi: 10.1016/j.idc.2019.02.004 – ident: e_1_2_16_174_1 doi: 10.7326/0003-4819-144-5-200603070-00010 – ident: e_1_2_16_13_1 doi: 10.1093/infdis/jiad268 – ident: e_1_2_16_191_1 doi: 10.1016/j.bbmt.2012.10.014 – ident: e_1_2_16_47_1 doi: 10.1128/JCM.06579-11 – ident: e_1_2_16_207_1 doi: 10.1038/bmt.2009.78 – ident: e_1_2_16_14_1 doi: 10.1038/s41408‐022‐00778‐3 – ident: e_1_2_16_226_1 doi: 10.1056/NEJMoa2106062 – ident: e_1_2_16_110_1 doi: 10.1056/NEJMoa2033130 – ident: e_1_2_16_177_1 doi: 10.1016/j.healun.2007.05.020 – ident: e_1_2_16_44_1 doi: 10.1016/j.jinf.2019.12.022 – ident: e_1_2_16_165_1 doi: 10.1016/S1473-3099(09)70175-6 – ident: e_1_2_16_197_1 doi: 10.3201/eid1309.070318 – ident: e_1_2_16_158_1 doi: 10.1182/blood-2009-11-255455 – volume: 1 year: 2023 ident: e_1_2_16_140_1 article-title: Remdesivir for the treatment of COVID‐19 publication-title: Cochrane Database Syst Rev – volume: 2 start-page: 203 year: 2012 ident: e_1_2_16_150_1 article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients publication-title: Am J Blood Res – ident: e_1_2_16_76_1 doi: 10.1111/tid.12111 – ident: e_1_2_16_79_1 doi: 10.3324/haematol.2016.153767 – ident: e_1_2_16_42_1 doi: 10.1093/cid/cis844 – ident: e_1_2_16_88_1 doi: 10.1111/tid.12926 – ident: e_1_2_16_35_1 doi: 10.1038/s41598-021-97700-x – ident: e_1_2_16_195_1 doi: 10.1111/j.1365-2141.2006.06108.x – ident: e_1_2_16_138_1 doi: 10.1086/375069 – ident: e_1_2_16_214_1 doi: 10.1182/blood.2022016202 – ident: e_1_2_16_109_1 doi: 10.1016/j.cmi.2022.04.018 – ident: e_1_2_16_145_1 doi: 10.1111/tid.12729 – ident: e_1_2_16_90_1 doi: 10.1016/j.bbmt.2009.12.534 – ident: e_1_2_16_100_1 doi: 10.1038/s41409‐023‐01946‐0 – ident: e_1_2_16_105_1 doi: 10.1016/j.bbmt.2018.07.006 – ident: e_1_2_16_134_1 doi: 10.1007/s40121-019-00271-8 – ident: e_1_2_16_21_1 doi: 10.1128/JCM.01816-15 – ident: e_1_2_16_176_1 doi: 10.1038/sj.bmt.1705781 – ident: e_1_2_16_17_1 doi: 10.1182/blood-2009-09-244152 – ident: e_1_2_16_142_1 doi: 10.1016/S2213-2600(21)00331-3 – ident: e_1_2_16_78_1 doi: 10.1016/j.bbmt.2018.12.005 – ident: e_1_2_16_101_1 doi: 10.3389/fimmu.2023.1125824 – ident: e_1_2_16_155_1 – ident: e_1_2_16_219_1 doi: 10.1128/CMR.00010‐16 – ident: e_1_2_16_228_1 doi: 10.1128/JVI.01659-16 – ident: e_1_2_16_113_1 doi: 10.1186/s12916-022-02518-7 – ident: e_1_2_16_68_1 doi: 10.1016/j.bbmt.2018.05.016 – ident: e_1_2_16_199_1 doi: 10.1111/tid.12167 – ident: e_1_2_16_203_1 doi: 10.1128/JCM.39.2.801-803.2001 – ident: e_1_2_16_65_1 doi: 10.1038/s41409‐020‐0943‐0 – ident: e_1_2_16_6_1 doi: 10.1038/s41409‐021‐01319‐5 – ident: e_1_2_16_186_1 doi: 10.1016/S0140‐6736(21)01594‐4 – ident: e_1_2_16_72_1 doi: 10.1093/infdis/jix264 – ident: e_1_2_16_225_1 doi: 10.3324/haematol.2018.206896 – volume: 35 start-page: S73 issue: 1 year: 2005 ident: e_1_2_16_192_1 article-title: Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity publication-title: Bone Marrow Transplant – ident: e_1_2_16_87_1 doi: 10.1038/s41409‐021‐01462‐z – ident: e_1_2_16_187_1 doi: 10.1016/j.jcv.2015.04.012 – ident: e_1_2_16_22_1 doi: 10.1128/JCM.01816-15 – ident: e_1_2_16_53_1 doi: 10.1093/cid/civ272 – ident: e_1_2_16_43_1 doi: 10.1093/cid/ciu134 – ident: e_1_2_16_89_1 doi: 10.1086/504268 – ident: e_1_2_16_7_1 doi: 10.1056/NEJMc2031364 – ident: e_1_2_16_19_1 doi: 10.14745/ccdr.v47i03a02 – ident: e_1_2_16_83_1 doi: 10.1111/j.1399‐3062.2008.00362.x – ident: e_1_2_16_181_1 doi: 10.1186/s13045‐022‐01275‐7 – ident: e_1_2_16_209_1 doi: 10.1016/j.bbmt.2018.03.004 – ident: e_1_2_16_96_1 doi: 10.1182/blood‐2011‐08‐371112 – ident: e_1_2_16_95_1 doi: 10.1182/blood.V98.3.573 – ident: e_1_2_16_40_1 doi: 10.1002/rmv.2375 – ident: e_1_2_16_124_1 doi: 10.1016/j.cmi.2021.05.020 – ident: e_1_2_16_107_1 doi: 10.1093/cid/ciy874 – ident: e_1_2_16_166_1 doi: 10.3109/10428194.2015.1113279 – ident: e_1_2_16_11_1 doi: 10.1093/cid/ciy792 – ident: e_1_2_16_27_1 doi: 10.1007/s40291-022-00580-8 – ident: e_1_2_16_217_1 doi: 10.1128/JVI.01631‐14 – ident: e_1_2_16_146_1 doi: 10.3390/v13081665 – ident: e_1_2_16_45_1 doi: 10.1016/j.bbmt.2012.11.139 – ident: e_1_2_16_63_1 doi: 10.1093/infdis/jit832 – ident: e_1_2_16_62_1 doi: 10.1093/infdis/jis610 – ident: e_1_2_16_169_1 doi: 10.1182/blood-2006-12-060343 – ident: e_1_2_16_129_1 doi: 10.1002/jmv.28471 – ident: e_1_2_16_159_1 doi: 10.1111/tid.12054 – ident: e_1_2_16_157_1 doi: 10.1016/j.jcv.2022.105152 – ident: e_1_2_16_221_1 doi: 10.1093/infdis/jix203 – ident: e_1_2_16_188_1 doi: 10.1093/cid/cix160 – ident: e_1_2_16_189_1 doi: 10.1111/tid.12022 – ident: e_1_2_16_26_1 doi: 10.1016/j.diagmicrobio.2015.10.025 – ident: e_1_2_16_175_1 doi: 10.1111/j.1365-2141.2009.07654.x – ident: e_1_2_16_156_1 doi: 10.1086/425004 – ident: e_1_2_16_230_1 doi: 10.1111/ejh.12094 – ident: e_1_2_16_77_1 doi: 10.1016/j.bbmt.2018.11.022 – ident: e_1_2_16_185_1 doi: 10.1016/j.ccell.2022.02.012 – ident: e_1_2_16_172_1 doi: 10.3109/10428194.2015.1067699 – ident: e_1_2_16_69_1 doi: 10.1093/jac/dkt111 – ident: e_1_2_16_206_1 doi: 10.1056/NEJMc2031670 – ident: e_1_2_16_112_1 doi: 10.1128/aac.00452-22 – volume-title: Specimen Collection Guidelines year: 2020 ident: e_1_2_16_37_1 – ident: e_1_2_16_151_1 doi: 10.1182/blood-2003-05-1425 – ident: e_1_2_16_106_1 doi: 10.1111/tid.12111 – ident: e_1_2_16_4_1 doi: 10.1182/blood‐2022‐167773 – ident: e_1_2_16_29_1 doi: 10.1016/j.cmi.2017.11.018 – ident: e_1_2_16_86_1 doi: 10.1038/s41409‐022‐01575‐z – ident: e_1_2_16_41_1 doi: 10.1128/cmr.00168-21 – ident: e_1_2_16_51_1 doi: 10.1182/bloodadvances.2021004915 – ident: e_1_2_16_213_1 doi: 10.3389/fimmu.2018.00678 – ident: e_1_2_16_227_1 doi: 10.1093/infdis/jiab611 – ident: e_1_2_16_123_1 doi: 10.1007/s00134-021-06448-5 – ident: e_1_2_16_163_1 doi: 10.1182/blood-2010-11-319186 – ident: e_1_2_16_111_1 doi: 10.1016/S1473-3099(20)30004-9 – ident: e_1_2_16_102_1 doi: 10.1097/QCO.0b013e3283480440 – year: 2022 ident: e_1_2_16_183_1 article-title: Breakthrough COVID‐19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey publication-title: Blood – ident: e_1_2_16_179_1 doi: 10.1111/tid.13792 – ident: e_1_2_16_31_1 doi: 10.1093/jac/dkab245 – ident: e_1_2_16_173_1 doi: 10.1007/s15010-012-0279-9 – ident: e_1_2_16_82_1 doi: 10.1182/blood-2013-12-541359 – ident: e_1_2_16_200_1 doi: 10.3324/haematol.2021.280407 – ident: e_1_2_16_223_1 doi: 10.1111/tid.13602 – ident: e_1_2_16_94_1 doi: 10.1016/j.ijid.2023.03.045 – ident: e_1_2_16_115_1 doi: 10.1093/infdis/jiac135 – ident: e_1_2_16_71_1 doi: 10.1093/ofid/ofy077 – ident: e_1_2_16_67_1 doi: 10.1038/s41409‐022‐01790‐8 – ident: e_1_2_16_98_1 doi: 10.1038/s41409‐018‐0386‐z – ident: e_1_2_16_149_1 doi: 10.1038/sj.bmt.1704359 – ident: e_1_2_16_161_1 doi: 10.1016/S1473‐3099(18)30600‐5 – ident: e_1_2_16_34_1 doi: 10.1128/spectrum.00503-22 – ident: e_1_2_16_164_1 doi: 10.1016/j.bbmt.2010.09.014 |
SSID | ssj0017949 |
Score | 2.4283 |
SecondaryResourceType | review_article |
Snippet | Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of... Before the COVID-19 pandemic, common community-acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well-being of... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e14117 |
SubjectTerms | adenovirus allogeneic stem cell transplantation Allografts community acquired respiratory virus (CARV) COVID-19 COVID-19 - epidemiology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells human adenovirus human bocavirus human metapneumovirus human parainfluenza virus human seasonal coronavirus Humans influenza virus Pandemics Respiratory Tract Infections - epidemiology respiratory virus rhinovirus SARS‐CoV‐2 Severe acute respiratory syndrome coronavirus 2 Stem cell transplantation Stem cells Transplantation vaccines.VRS Viral diseases Viruses |
Title | Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftid.14117 https://www.ncbi.nlm.nih.gov/pubmed/37585370 https://www.proquest.com/docview/2899282375 https://www.proquest.com/docview/2852632826 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1399-3062 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0017949 issn: 1398-2273 databaseCode: ABDBF dateStart: 19990301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1398-2273 databaseCode: DR2 dateStart: 19990101 customDbUrl: isFulltext: true eissn: 1399-3062 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017949 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iyYsPfK0vonjwsF3apmkSPYm6qAcPi8IehJKkqSxKFdt68OofN5M-XF8g3ko7Ja-ZzEwy8w1C-3EkFadaeyEz2oukNh5Xqe8JbpVzpiIqjAuQvYrPb6LLMR3PoKM2F6bGh-gO3EAy3H4NAi5VMSXk5SS1Yh4EkEkeEOquaEcddBTwmXDOlrCcYHV0gyoEUTzdn5910TcD87O96hTOcAHdtl2t40zuB1WpBvr1C4rjP8eyiOYbQxQf15yzhGZMvozeRh837_hl8lwVuI3Wygvs6oljuKm3XGcmGgMINIajf1w6jPQHWScy5Ye4wX3C1XTyTB93R3j4Tj4VfWzfY7vnAmUTjVCsoJvh2fXJudeUafA0oYR5ggRhzAhVlBgW6YDFQspUKWatOeVDvUDBspBnkTI85T5PNfPTlIciDLRkPCWraDZ_zM06wplgJpYy1lKxKOZacJppSiKmFdGGyR46aBcs0Q2GOZTSeEhaX8bOZOJmsof2OtKnGrjjJ6KtdtWTRnaLBFzQEDB8aA_tdp-t1MF8ytw8VkBDAeje-mY9tFZzS9cKAReMMN921q35780n1xen7mHj76SbaA4q3tfpkFtotnyuzLa1i0q14wTgHbSSC58 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BPZRLS1UeS4G6VQ89EJTEcWwjLgiKlpZyQIvEBUW246BVVwGRhEOv_eN4nEehFKnqLUomcmLPeB6e-QbgU5ooLZgxQcytCRJlbCB0HgZSOOVc6IRJ6xNkT9PxefL1gl3MwV5fC9PiQwwBN5QMv1-jgGNA-oGU19PcyXkU8Xl4gedzKJaHZwN4FHKa9O6WdLzgtHSHK4R5PMOrj7XRExPzscXqVc7Ra7jsP7bNNPmx09R6x_z8A8fxf_9mCV51tijZb5nnDczZ8i38Ovt9-E7uprdNRfqErbIivqU4wcN6x3h2agjiQBOM_pPaw6TPVFvLVO6SDvqJNA_rZ7bJEMUjV-qm2ibuPnHbLlJ2CQnVMpwffZkcjIOuU0NgKKM8kDSKU06ZZtTyxEQ8lUrlWnNn0OkQWwZKXsSiSLQVuQhFbniY5yKWcWQUFzldgYXyurRrQArJbapUapTmSSqMFKwwjCbcaGosVyP43K9YZjoYc-ymMct6d8bNZOZncgQfB9KbFrvjb0Qb_bJnnfhWGXqhMcL4sBF8GB47wcP5VKW9bpCGIda9c89GsNqyyzAKRS-M8tB9rF_054fPJseH_mL930nfw8vx5PtJdnJ8-u0dLMbO7GqrIzdgob5t7KYzk2q95aXhHljpD7s |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3La9ZAEB9qBfFiKz762VZX8eChKUl2N7urJ7F-tCpFSgs9CGFfkQ9L-tEkPfTqP-7O5mHrA8RbSCbsa2ZnZnfmNwAvC6aN5NYmufA2Ydr6RBqXJkoG5VwZxpWPAbKHxf4J-3DKT1fgzZgL0-NDTAduKBlxv0YBX7rqmpC3CxfEPMvELbjNiuBdoUV0NGFHIaOp6G2pwApBSQ-wQhjGM_16Uxn9ZmHeNFijxpmvwZexr32gybfdrjW79uoXGMf_HMw63BssUfK2Z537sOLrB_D96OfVO7lcXHQNGcO16obEguIEr-oD2_mFJYgCTfDsn7QRJP1M95lM9WsyAD-R7nr2zA6ZzvDIV71sdkh4T8Kmi5RDOELzEE7m74_f7SdDnYbEUk5FomiWF4Jyw6kXzGaiUFo7Y0Qw50yKBQOVqHJZMeOlk6l0VqTOyVzlmdVCOvoIVuvz2m8AqZTwhdaF1UawQloleWU5ZcIaar3QM3g1LlhpBxBzrKVxVo7OTJjJMs7kDF5MpMseueNPRFvjqpeD8DYl-qA5gvjwGTyfPgexw_nUtT_vkIYj0n1wzmbwuOeWqRWKPhgVaehsXPO_N18eH-zFhyf_TvoM7nzem5efDg4_bsLdPNhcfWrkFqy2F53fDjZSa55GWfgBKOoOag |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Respiratory+virus+infections+after+allogeneic+stem+cell+transplantation%3A+Current+understanding%2C+knowledge+gaps%2C+and+recent+advances&rft.jtitle=Transplant+infectious+disease&rft.au=Pi%C3%B1ana%2C+Jose+L&rft.au=P%C3%A9rez%2C+Ariadna&rft.au=Chor%C3%A3o%2C+Pedro&rft.au=Guerreiro%2C+Manuel&rft.date=2023-11-01&rft.eissn=1399-3062&rft.volume=25+Suppl+1&rft.spage=e14117&rft_id=info:doi/10.1111%2Ftid.14117&rft_id=info%3Apmid%2F37585370&rft.externalDocID=37585370 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-2273&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-2273&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-2273&client=summon |